PL362571A1 - Pochodne beta-karboliny i ich zastosowanie farmaceutyczne przeciwko depresji i lękowi - Google Patents

Pochodne beta-karboliny i ich zastosowanie farmaceutyczne przeciwko depresji i lękowi

Info

Publication number
PL362571A1
PL362571A1 PL02362571A PL36257102A PL362571A1 PL 362571 A1 PL362571 A1 PL 362571A1 PL 02362571 A PL02362571 A PL 02362571A PL 36257102 A PL36257102 A PL 36257102A PL 362571 A1 PL362571 A1 PL 362571A1
Authority
PL
Poland
Prior art keywords
anxiety
beta
pharmaceutical use
use against
carboline derivatives
Prior art date
Application number
PL02362571A
Other languages
English (en)
Other versions
PL210861B1 (pl
Inventor
Thomas J. Troxler
Konstanze Hurth
Daniel Hoyer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL362571A1 publication Critical patent/PL362571A1/pl
Publication of PL210861B1 publication Critical patent/PL210861B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL362571A 2001-04-03 2002-04-02 Pochodna beta-karboliny,kompozycja farmaceutyczna zawierająca pochodną beta-karboliny oraz zastosowanie pochodnej beta-karboliny PL210861B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0108337.7A GB0108337D0 (en) 2001-04-03 2001-04-03 Organic compounds
PCT/EP2002/003624 WO2002081471A1 (en) 2001-04-03 2002-04-02 Beta-carboline derivatives and its pharmaceutical use against depression and anxiety

Publications (2)

Publication Number Publication Date
PL362571A1 true PL362571A1 (pl) 2004-11-02
PL210861B1 PL210861B1 (pl) 2012-03-30

Family

ID=9912165

Family Applications (1)

Application Number Title Priority Date Filing Date
PL362571A PL210861B1 (pl) 2001-04-03 2002-04-02 Pochodna beta-karboliny,kompozycja farmaceutyczna zawierająca pochodną beta-karboliny oraz zastosowanie pochodnej beta-karboliny

Country Status (27)

Country Link
US (1) US6861430B2 (pl)
EP (1) EP1377578B1 (pl)
JP (1) JP4405732B2 (pl)
KR (1) KR100564840B1 (pl)
CN (1) CN1309721C (pl)
AR (1) AR035451A1 (pl)
AT (1) ATE517104T1 (pl)
AU (1) AU2002316828B2 (pl)
BR (1) BR0208566B1 (pl)
CA (1) CA2440014C (pl)
CZ (1) CZ295992B6 (pl)
EC (1) ECSP034754A (pl)
ES (1) ES2368389T3 (pl)
GB (1) GB0108337D0 (pl)
HU (1) HUP0400317A3 (pl)
IL (1) IL157545A0 (pl)
MX (1) MXPA03009057A (pl)
MY (1) MY134026A (pl)
NO (1) NO20034413D0 (pl)
NZ (1) NZ528370A (pl)
PE (1) PE20021018A1 (pl)
PL (1) PL210861B1 (pl)
PT (1) PT1377578E (pl)
RU (1) RU2003130644A (pl)
SK (1) SK12222003A3 (pl)
WO (1) WO2002081471A1 (pl)
ZA (1) ZA200306108B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
US7872133B2 (en) * 2003-06-23 2011-01-18 Ono Pharmaceutical Co., Ltd. Tricyclic heterocycle compound
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
EP1829874B1 (en) 2004-12-22 2014-02-12 Ono Pharmaceutical Co., Ltd. Tricyclic compound and use thereof
US7879859B2 (en) * 2005-11-21 2011-02-01 Merck Sharp & Dohme Corp. Diagnosis and treatment of type 2 diabetes and other disorders
US20070149557A1 (en) * 2005-11-21 2007-06-28 Amgen Inc. CXCR3 antagonists
EP2178537A4 (en) * 2007-07-19 2011-08-17 Merck Sharp & Dohme BETA-CARBOLIN DERIVATIVES AS ANTIDIBLE COMPOUNDS
WO2009016329A1 (en) * 2007-07-31 2009-02-05 Cambridge Enterprise Limited Use of gabaa receptor antagonists to treat cognitive impairment in patients with psychiatric conditions
CN102131805A (zh) 2008-06-20 2011-07-20 百时美施贵宝公司 用作激酶抑制剂的咪唑并吡啶和咪唑并吡嗪化合物
LT2889033T (lt) 2008-11-19 2018-07-10 Forum Pharmaceuticals Inc. Šizofrenijos negatyvių simptomų gydymas (r)-7-chlor-n-(chinuklidin-3-il)benzo[b]tiofen-2-karboksamidu ir jo farmaciniu požiūriu priimtinomis druskomis
TW201028414A (en) * 2009-01-16 2010-08-01 Merck Sharp & Dohme Oxadiazole beta carboline derivatives as antidiabetic compounds
WO2011088025A1 (en) 2010-01-15 2011-07-21 Merck Sharp & Dohme Corp. Oxadiazole beta carboline derivatives as antidiabetic compounds
PE20170923A1 (es) 2010-05-17 2017-07-12 Forum Pharmaceuticals Inc Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidratado
EP3461481A1 (en) 2012-05-08 2019-04-03 Forum Pharmaceuticals Inc. Methods of maintaining, treating or improving cognitive function
CN111349096B (zh) * 2020-04-14 2021-03-09 石河子大学 一种吲哚类化合物及其制备方法、应用
KR102467844B1 (ko) 2021-04-21 2022-11-16 삼성전자주식회사 솔리드 스테이트 드라이브 장치 및 이를 포함하는 데이터 저장 장치

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4118741A1 (de) 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
US6057340A (en) 1998-02-03 2000-05-02 American Home Products Corporation Oxazole derivatives as serotonin-1A receptor agonists
HUP0302962A2 (hu) 1998-06-12 2003-12-29 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása

Also Published As

Publication number Publication date
BR0208566A (pt) 2004-03-30
HUP0400317A3 (en) 2007-10-29
BR0208566B1 (pt) 2013-12-24
CZ295992B6 (cs) 2005-12-14
JP4405732B2 (ja) 2010-01-27
IL157545A0 (en) 2004-03-28
ZA200306108B (en) 2004-07-05
AR035451A1 (es) 2004-05-26
PL210861B1 (pl) 2012-03-30
CN1500090A (zh) 2004-05-26
EP1377578A1 (en) 2004-01-07
CZ20032655A3 (cs) 2003-12-17
MXPA03009057A (es) 2004-02-12
MY134026A (en) 2007-11-30
NO20034413L (no) 2003-10-02
RU2003130644A (ru) 2005-04-10
EP1377578B1 (en) 2011-07-20
HUP0400317A2 (hu) 2004-09-28
US20040132735A1 (en) 2004-07-08
ATE517104T1 (de) 2011-08-15
US6861430B2 (en) 2005-03-01
AU2002316828B2 (en) 2006-05-11
ECSP034754A (es) 2003-10-28
CN1309721C (zh) 2007-04-11
PT1377578E (pt) 2011-09-23
CA2440014A1 (en) 2002-10-17
NZ528370A (en) 2005-10-28
WO2002081471A1 (en) 2002-10-17
KR20040008150A (ko) 2004-01-28
CA2440014C (en) 2010-11-23
GB0108337D0 (en) 2001-05-23
SK12222003A3 (sk) 2004-06-08
KR100564840B1 (ko) 2006-03-28
NO20034413D0 (no) 2003-10-02
JP2004525178A (ja) 2004-08-19
ES2368389T3 (es) 2011-11-16
PE20021018A1 (es) 2003-01-13

Similar Documents

Publication Publication Date Title
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
HUP0300746A3 (en) Proline derivatives and use thereof as drugs
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
PL377854A1 (pl) Farmaceutyczne preparaty donosowe oraz sposoby ich stosowania
PT1296974E (pt) Derivados 2-cianopirrolidina e sua utilização como medicamentos
EP1423120A4 (en) 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
IL159275A0 (en) Phenylsulfonyl-1, 3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
IL150734A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
PL362571A1 (pl) Pochodne beta-karboliny i ich zastosowanie farmaceutyczne przeciwko depresji i lękowi
GB0108470D0 (en) Pharmaceutical compositions and their use
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
HUP0402028A3 (en) Unsaturated 1-amino-alkylcyclohexane derivatives, pharmaceutical compositions containing them and use thereof
PL367676A1 (pl) Nowe pochodne heterocykliczne i ich zastosowanie w medycynie
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
IL153487A0 (en) Pharmaceutical compositions and methods for use
IL153897A0 (en) Pharmaceutical compositions and methods for use
EP1407771A4 (en) SOPHORIDINE AND ITS USE AS ANALYZIC
AUPR916301A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR606401A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
IL158266A0 (en) Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140402